When a customer asks whether your product contains phthalates, can you explain *why* DEHCH qualifies as phthalate-free — or are you just repeating what the supplier told you? The classification is chemically definitive, not a marketing label. DEHCH is not a phthalate. It is a cyclohexanoate diester, structurally distinct from any phthalate compound. But that answer only becomes useful when you understand the molecular logic behind it — and that is exactly what most technical data sheets leave out.
What Makes a Plasticizer a Phthalate
A phthalate is an ester of phthalic acid — specifically, benzene-1,2-dicarboxylic acid. That benzene ring with two adjacent carboxyl groups is the defining structural feature. Every regulated phthalate — DEHP, DBP, BBP, DIBP — shares this backbone. Change the alcohol chain and you get different phthalates. But the acid core stays the same.
DEHCH’s full IUPAC name is bis(2-ethylhexyl) cyclohexane-1,4-dicarboxylate. The classification answer is embedded right in the name: *cyclohexane*, not benzene. The acid backbone is cyclohexane-1,4-dicarboxylic acid, a six-membered ring of carbon atoms with no aromatic character.
How Hydrogenation Changes the Classification
The manufacturing process makes the distinction concrete. DEHCH is produced by catalytic hydrogenation of DOTP (DEHT), the terephthalate isomer of DEHP. Hydrogen saturates the aromatic benzene ring, converting it to a cyclohexane ring. This is not a minor modification — it fundamentally changes the chemical identity. The resulting diester no longer contains a benzene ring, so it is not a phthalate by any chemical definition.
The molecular structure explains why this matters beyond nomenclature. Phthalic acid’s planar aromatic ring is part of the structure linked to the fetal testosterone suppression behind phthalate restrictions. Cyclohexane’s non-planar, saturated ring does not share that geometry. The structural change is not cosmetic — it alters the molecule’s biological interaction profile.
Think of it this way: DEHCH and DEHP share the same 2-ethylhexyl alcohol side chains. The difference is entirely in the acid backbone. That twofold structural distinction — a saturated rather than aromatic ring, with the ester groups at the 1,4 rather than DEHP’s 1,2 positions — is what moves DEHCH out of the phthalate family.
DEHCH on Restricted Phthalate Lists
DEHCH (CAS 84731-70-4) does not appear on any major restricted phthalate list — EU, US, or international.
The EU regulates eight specific phthalates under REACH Annex XVII, the REACH Candidate List and RoHS, with a concentration threshold of 0.1% by weight: DEHP (117-81-7), BBP (85-68-7), DBP (84-74-2), DIBP (84-69-5), DCHP (84-61-7), DNOP (117-84-0), DIDP (26761-40-0), and DINP (68515-48-0). DEHCH’s CAS number is absent from every entry. The same applies to the US CPSC phthalate prohibitions under 16 CFR part 1307, and California Proposition 65.
FDA cleared DEHCH for food-contact materials in 2017, and EU food-contact authorization followed in 2023, after EFSA’s 2019 safety assessment. These approvals evaluated DEHCH as a distinct substance, not as a phthalate variant receiving an exemption.
One practical point for compliance documentation: when auditors ask about phthalate content, the CAS number is your most defensible reference. CAS 84731-70-4 maps to cyclohexane-1,4-dicarboxylic acid ester chemistry, not phthalic acid chemistry. That mapping is unambiguous and auditor-verifiable.
Safety Evidence Beyond Classification
Non-phthalate status is a structural chemistry fact, not a safety guarantee. The two questions — “Is it a phthalate?” and “Is it safe?” — require separate evidence chains. Conflating them is a mistake I see frequently in technical marketing, and it weakens your compliance position rather than strengthening it.
The independent safety data for DEHCH is strong. Hughes et al. derived an oral reference dose (RfD) of 0.3 mg/kg-day based on OECD 422 combined studies that found minimal effects on liver, spleen, and thyroid, and no indication of developmental or reproductive toxicity. Genotoxicity screening showed low genotoxic potential with no mutagenicity or clastogenicity. The uncertainty factor was conservative at 100x.
More recent work by Kang et al. (2025, *Journal of Hazardous Materials*) tested DEHCH directly against conventional phthalates and other alternatives in zebrafish models. DEHCH did not show the highest binding affinity for any of five hormone receptors, had no agonistic or antagonistic effects on estrogen or androgen receptors, and no effects on endocrine-related gene expression. DEHP, DINCH, and DEHTP all induced hyperactivity in the same model — DEHCH did not.
The structural change that removes DEHCH from the phthalate classification also eliminates the endocrine disruption mechanism that motivated phthalate restrictions in the first place. The chemistry and the biology align. But the safety case rests on empirical testing, not on classification logic alone.
The Classification Logic in Three Steps
DEHCH’s non-phthalate status follows a straightforward chain: the molecule derives from cyclohexane-1,4-dicarboxylic acid, not phthalic acid, so it is not a phthalate ester by chemical definition. Regulatory lists confirm this — CAS 84731-70-4 appears on zero restricted phthalate registers worldwide. Independent toxicological data validates that the structural distinction carries biological significance.
When communicating this to auditors or supply chain partners, lead with the CAS number and the acid backbone identity. That gives them a verifiable, chemistry-based answer rather than a marketing claim they have to take on faith.